Relationship between striatal levels of interleukin-2 mRNA and plus-maze behaviour in the rat

被引:36
作者
Pawlak, CR
Ho, YJ
Schwarting, RKW
Bauhofer, A
机构
[1] Univ Marburg, D-35032 Marburg, Germany
[2] Chung Shan Med Univ, Sch Psychol, Div Clin Psychol, Taichung, Taiwan
[3] Univ Marburg, Inst Theoret Surg, D-35043 Marburg, Germany
关键词
interleukin-2; interleukin-1; cytokines; anxiety; striatum; rat behaviour; plus-maze;
D O I
10.1016/S0304-3940(03)00184-8
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Our previous experiments have shown that adult male Wistar rats can differ systematically in elevated plus-maze (EPM) behaviour, which was related to the neurotransmitter serotonin in the ventral striatum. The EPM serves as a model of anxiety-like behaviour, and there is evidence that interleukin (IL)-2 in the brain may be related to anxiety-like behaviour, and that IL-2 interacts with the striatal serotonergic system. We asked whether EPM behaviour may also be related to constitutive levels of cytokines in the striatum. Based on open arm time in the EPM, male Wistar rats were divided into sub-groups with either low or high anxiety-like behaviour. Then, IL-1beta, IL-2, IL-6, and tumour necrosis factor (TNF)-alpha cDNA levels were measured post mortem in striatal tissues using semi-quantitative, competitive, reverse transcription polymerase chain reaction. Rats with high anxiety-like behaviour in the EPM showed significantly higher levels of IL-2 mRNA compared to those with low anxiety-like behaviour, but did not differ significantly in expression of IL-1beta, IL-6, and TNF-alpha mRNA. These results provide new evidence indicating that specific cytokine patterns in the striatum may be associated with EPM behaviour in adult male Wistar rats. (C) 2003 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:205 / 208
页数:4
相关论文
共 22 条
  • [1] Anisman H, 1999, ADV EXP MED BIOL, V461, P199
  • [2] Quality of life in animals as a new outcome for surgical research: G-CSF as a quality of life improving factor
    Bauhofer, A
    Witte, K
    Lemmer, B
    Middeke, M
    Lorenz, W
    Celik, I
    [J]. EUROPEAN SURGICAL RESEARCH, 2002, 34 (1-2) : 22 - 29
  • [3] Negative symptoms: the 'pathology' of motivation and goal-directed behaviour
    Brown, RG
    Pluck, G
    [J]. TRENDS IN NEUROSCIENCES, 2000, 23 (09) : 412 - 417
  • [4] An assessment of the effects of central interleukin-1β, -2, -6, and tumor necrosis factor-α administration on some behavioural, neurochemical, endocrine and immune parameters in the rat
    Connor, TJ
    Song, C
    Leonard, BE
    Merali, Z
    Anisman, H
    [J]. NEUROSCIENCE, 1998, 84 (03) : 923 - 933
  • [5] Nijmegen high and low responders to novelty: A new tool in the search after the neurobiology of drug abuse liability
    Cools, AR
    Gingras, MA
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1998, 60 (01) : 151 - 159
  • [6] EIZENBERG O, 1995, J NEUROCHEM, V64, P1928
  • [7] Role of 5-HT in stress, anxiety, and depression
    Graeff, FG
    Guimaraes, FS
    DeAndrade, TGCS
    Deakin, JFW
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1996, 54 (01) : 129 - 141
  • [8] Interleukin-2 as a neuroregulatory cytokine
    Hanisch, UK
    Quirion, R
    [J]. BRAIN RESEARCH REVIEWS, 1995, 21 (03) : 246 - 284
  • [9] Unconditioned anxiety and social behaviour in two rat lines selectively bred for high and low anxiety-related behaviour
    Henniger, MSH
    Ohl, F
    Hölter, SM
    Weissenbacher, P
    Toschi, N
    Lörscher, P
    Wigger, A
    Spanagel, R
    Landgraf, R
    [J]. BEHAVIOURAL BRAIN RESEARCH, 2000, 111 (1-2) : 153 - 163
  • [10] Individual response profiles of male Wistar rats in animal models for anxiety and depression
    Ho, YJ
    Eichendorff, J
    Schwarting, RKW
    [J]. BEHAVIOURAL BRAIN RESEARCH, 2002, 136 (01) : 1 - 12